Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
its a testament to the ongoing pursuit of groundbreaking solutions to transform lives
A disease-specific metabolic pattern based on 18 F-fluorodexyglucose (FDG)-PET has been developed and repeatedly validated in PD populations and has also been suggested as an objective tool of tracking treatment effect in clinical trials (Schindlbeck et al
Enhancing comfort: Reduces potential discomfort during injections
Zhou Y, Wu H, Li S, Chen Q, Cheng XW, Zheng J et al (2006)
US$ 25.30
US$ 24.07
US$ 20.14
